On September 7, 2022 SQZ Biotechnologies Company (NYSE: SQZ), focused on unlocking the full potential of cell therapies for multiple therapeutic areas, reported that Armon Sharei, Ph.D., Chief Executive Officer and Founder at SQZ Biotechnologies, will present at the H.C. Wainwright 24th Annual Global Investment Conference on September 14 and at the Chardan 6th Annual Genetic Medicines Conference on October 4 (Press release, SQZ Biotech, SEP 7, 2022, View Source [SID1234619203]). Both conference presentations will be held in New York, NY. Presentation times and webcast information are available below.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

PRESENTATION DETAILS

Wednesday, September 14
H.C. Wainwright 24th Annual Global Investment Conference
11:00-11:30 a.m. ET
Webcast

Tuesday, October 4
Chardan 6th Annual Genetic Medicines Conference
1:30-2:00 p.m. ET
Webcast

Conference webcast details and the company’s most recent corporate overview presentation will be available on the Investors section of the SQZ website. Replays will be available for 60 days.

Based on guidance from the SEC, investors should note that the company may announce future healthcare conference presentations on the Events & Presentations page within the Investor Relations section of its corporate website, investors.sqzbiotech.com. It is possible that the information posted there could be deemed to be material information.